A comprehensive view of New Drug / Biologic License Application (NDA / BLA). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

US Patent Issued to Bristol-Myers Squibb on April 23 for "Substituted bicyclic compounds useful as T cell activators" (American, Indian Inventors)
Published: April 24, 2024 by U.S. Fed News
US Patent Issued to Regeneron Pharmaceuticals on April 23 for "Methods and compositions for sensitization of tumor cells to immune therapy" (New York, New Jersey Inventors)
Published: April 24, 2024 by U.S. Fed News
FDA accepts for priority review GSK’s application for an expanded indication of Jemperli dostarlimab-gxly plus chemotherapy to include all adult patients with primary advanced or recurrent endometrial cancer
Published: April 24, 2024 by GSK Group (GlaxoSmithKline)
US Patent Issued to ELI LILLY and Co. on April 23 for "Compounds useful for inhibiting RET kinase" (Colorado, Montana Inventors)
Published: April 24, 2024 by U.S. Fed News
US Patent Issued to REGENERON PHARMACEUTICALS on April 23 for "Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for treating allergy" (New York Inventors)
Published: April 24, 2024 by U.S. Fed News

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count